Calliditas announces an additional seven year orphan drug exclusivity period for TARPEYO® March 6, 2024 08:15 CET Regulatory Read more
Calliditas Therapeutics to Attend Investor Conferences in March March 1, 2024 13:00 CET Non Regulatory Read more
Invitation to the presentation of Calliditas´ Year-end report January – December 2023 February 14, 2024 07:00 CET Non Regulatory Read more
Calliditas Therapeutics provides business update ahead of JP Morgan conference January 8, 2024 08:15 CET Regulatory Read more
Calliditas Therapeutics appoints Maria Törnsén as President North America January 7, 2024 17:00 CET Non Regulatory Read more
Calliditas to present at JP Morgan Healthcare Conference January 7, 2024 15:00 CET Non Regulatory Read more